TeleTrader 28/07/2022 Merck: EPS more than triples to $1.55 in Q2
TeleTrader 24/06/2022 Merck advances in talks to acquire Seagen - report
TeleTrader 17/06/2022 Merck discussing buying Seagen for $28B - report
TeleTrader 28/04/2022 Merck's Q1 EPS up 57% to $1.70
TeleTrader 16/03/2022 Merck halts new Russia investments
TeleTrader 17/02/2022 South Africa authorizes Merck's COVID drug
GlobeNewswire 10/02/2022 Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Cl...
GlobeNewswire 03/02/2022 Arch Scientists Publish Data on the Mechanism of Action and Efficacy of Lead Drug Candidate LSALT Pe...
TeleTrader 03/02/2022 Merck's sales up by 24% to $13.52 billion in Q4
TeleTrader 18/01/2022 Merck, Ridgeback to supply 3 million courses of molnupiravir
GlobeNewswire 11/01/2022 Aligos Therapeutics Expands Collaboration with Merck to Develop Oligonucleotide Therapies for NASH
GlobeNewswire 11/01/2022 Yumanity’s Approach to Neurodegenerative Diseases Validated by Two External Collaborations
GlobeNewswire 10/01/2022 NGM Bio Outlines 2022 Strategic Priorities Across Its Portfolio of Clinical-Stage Oncology, Retinal ...
GlobeNewswire 10/01/2022 Neoleukin Therapeutics Announces Clinical Collaboration with Merck to Evaluate NL-201 in Combination...
TeleTrader 09/01/2022 Italy to get 40,000 Merck COVID-19 pills next week
GlobeNewswire 07/01/2022 Absci Announces Research Collaboration with Merck
GlobeNewswire 05/01/2022 F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in ...
TeleTrader 28/12/2021 India approves use of Merck's COVID-19 pill
TeleTrader 24/12/2021 Merck's antiviral pill approved in Japan
TeleTrader 23/12/2021 Pfizer, Merck pills effective against Omicron - FDA official
TeleTrader 23/12/2021 FDA approves Merck's COVID-19 pill
TeleTrader 16/12/2021 Denmark grants Merck's COVID pill limited approval
GlobeNewswire 14/12/2021 Merck, Procter & Gamble Among Private-Sector Partners Launching Research to the ISS on SpaceX CRS-24
GlobeNewswire 14/12/2021 HiberCell to Collaborate with Merck on Phase 2 Clinical Trial of Odetiglucan in Combination with KEY...
GlobeNewswire 06/12/2021 NGM Bio Announces Clinical Trial Collaboration with Merck Related to Ongoing Phase 1/2 Trial of NGM7...